Blood test may predict liver cancer treatment success
NCT ID NCT04459468
First seen Jan 09, 2026 · Last updated Jun 11, 2026 · Updated 27 times
Summary
This study enrolled 17 adults with liver cancer who were scheduled for standard treatments like TACE, ablation, or Y90. Researchers took blood samples before and after treatment to search for proteins (biomarkers) that might predict how well a patient responds. No new treatment was given; the goal was simply to gather information for future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
UT Southwestern Medical Center
Dallas, Texas, 75390, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.